Literature DB >> 11314937

Analysis of the survival period in resectable stage IV gastric cancer.

S Takeno1, T Noguchi, R Kikuchi, T Sato, Y Uchida, S Yokoyama.   

Abstract

BACKGROUND: Patients with stage IV gastric cancer usually have a poor prognosis, but some patients with resectable cancer survive for more than 5 years. We aimed to study the correlation of protein expression and survival in resectable stage IV gastric cancer. PATIENTS AND METHODS: Tissue samples of 42 patients with resectable stage IV gastric cancer were stained immunohistochemically for the mutant p53 protein and heat shock protein-27 (hsp27). The correlation between protein expression and clinicopathological factors was investigated. Furthermore, prognostic value of each factor was analyzed.
RESULTS: Univariate analysis showed that pN factors (Japanese classification, P = .028; International Union Against Cancer classification, P = .024), blood vessel invasion (P = .043), hsp27 overexpression (P = .019), and the index of p53 and hsp27 overexpression (P = .0026) had a prognostic influence. Only Lauren classification, however, revealed the prognostic influence in multivariate analysis (P = .046).
CONCLUSIONS: These results suggest that immunostaining of tumor specimens for p53 and hsp27 and clinicopathological analysis may help predict the survival of patients with resectable stage IV gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11314937     DOI: 10.1007/s10434-001-0215-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

1.  Survival benefit of non-curative gastrectomy for gastric cancer patients with synchronous distant metastasis.

Authors:  Chen Li; Min Yan; Jun Chen; Min Xiang; Zheng Gang Zhu; Hao Ran Yin; Yan Zheng Lin
Journal:  J Gastrointest Surg       Date:  2009-11-25       Impact factor: 3.452

2.  Retrospective analysis of stage IV advanced gastric cancer treated with S-1 or other chemotherapy.

Authors:  Kohei Shitara; Atushi Ishiguro; Masaki Munakata; Ryouichi Wada; Yuh Sakata
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

3.  Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro.

Authors:  Zhenkun Zhu; Xin Xu; Yanke Yu; Martin Graham; Mark E Prince; Thomas E Carey; Duxin Sun
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

4.  Promoter methylation of heat shock protein B2 in human esophageal squamous cell carcinoma.

Authors:  Xiaofei Chang; Keishi Yamashita; David Sidransky; Myoung Sook Kim
Journal:  Int J Oncol       Date:  2011-01-21       Impact factor: 5.650

Review 5.  Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications.

Authors:  Daniel R Ciocca; Stuart K Calderwood
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

6.  Prognosis of pN3 stage gastric cancer.

Authors:  Jung Ryun Ahn; Minkyu Jung; Chan Kim; Min Hee Hong; Hong Jae Chon; Hye Ryun Kim; Hei-Cheul Jeung; Woo Jin Hyung; Sung Sook Lee; Hyun Cheol Chung; Sung Hoon Noh; Sun Young Rha
Journal:  Cancer Res Treat       Date:  2009-06-30       Impact factor: 4.679

7.  Palliative gastrectomy and chemotherapy for stage IV gastric cancer.

Authors:  Sheng-Zhang Lin; Hong-Fei Tong; Tao You; Yao-Jun Yu; Wei-Jun Wu; Cong Chen; Wei Zhang; Bing Ye; Chun-Ming Li; Zhi-Qiang Zhen; Jia-Rong Xu; Jun-Liang Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-05       Impact factor: 4.553

8.  Differential proteomic analysis of noncardia gastric cancer from individuals of northern Brazil.

Authors:  Mariana Ferreira Leal; Janete Chung; Danielle Queiroz Calcagno; Paulo Pimentel Assumpção; Samia Demachki; Ismael Dale Cotrim Guerreiro da Silva; Roger Chammas; Rommel Rodríguez Burbano; Marília de Arruda Cardoso Smith
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

9.  Heat Shock Protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival.

Authors:  Constantinos Giaginis; Stella S Daskalopoulou; Stephanie Vgenopoulou; Ioannis Sfiniadakis; Gregorios Kouraklis; Stamatios E Theocharis
Journal:  BMC Gastroenterol       Date:  2009-02-09       Impact factor: 3.067

10.  Dysregulation of heat shock protein 27 expression in oral tongue squamous cell carcinoma.

Authors:  Anxun Wang; Xiqiang Liu; Shihu Sheng; Hui Ye; Tingsheng Peng; Fei Shi; David L Crowe; Xiaofeng Zhou
Journal:  BMC Cancer       Date:  2009-06-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.